Today’s Solutions: April 21, 2024

 Late “Jeopardy!” host Alex Trebek collected quite the extensive wardrobe in his more than 35 years hosting the game show. After his passing last year, his family has decided to donate a significant portion of his wardrobe to The Doe Fund to help those in need get back on their feet. 

The Doe Fund provides job training, resources, and support to those who have experienced addiction, homelessness, and incarceration. Part of their services is their Ready, Willing & Able program, which offers professional clothing for interviews so individuals can put their best foot forward in seeking professional opportunities. 

According to Trebek’s family, the donation included 14 suits, 300 neckties, 15 belts, 58 dress shirts, 25 polo shirts, 14 sweaters, nine pairs of dress shoes, nine sports coats, two parkas, and three pairs of dress slacks. The donation was suggested by Trebek’s son, Matthew, who is involved with The Doe Fund and suggested this would be a great opportunity to honor his father’s wish of continuing to use Jeopardy! to provide support to those most in need. 

Harriet McDonald, president of The Doe Fund, told CBS, “The men in our career training programs are always in need of professional attire, so they can shine in their job interviews and work with confidence once they’re hired.”

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More